Karin van der Tuuk
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Karin van der Tuuk has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
- Henk Groen
Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
3 shared publications - Maria Gabriel Van Pampus
OLVG Department Obstetrics and Gynecology
3 shared publications Corine M. Koopmans
Department of Obstetrics and Gynecology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
2 shared publicationsFrans J.A. Copraij
Department of Obstetrics and Gynecology, Diaconessenhuis, Leiden, The Netherlands
2 shared publicationsGunilla Kleiverda
Department of Obstetrics and Gynecology, Flevoziekenhuis, Almere, The Netherlands
2 shared publicationsJan G. Aarnoudse
Department of Obstetrics and Gynecology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
2 shared publications
Latest Publications
- 1 August 2015
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 191, 23-27
Prediction of cesarean section risk in women with gestational hypertension or mild preeclampsia at term
- 1 August 2015
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 191, 23-27
Prediction of cesarean section risk in women with gestational hypertension or mild preeclampsia at term
- 1 March 2013
- Published by Wolters Kluwer Health in Obstetric Anesthesia Digest
- Vol. 33 (1) , 25-26
Impact of the HYPITAT Trial on Doctors’ Behaviour and Prevalence of Eclampsia in the Netherlands
(BJOG. 2011;118(13):1658-1660)
- 1 March 2013
- Published by Wolters Kluwer Health in Obstetric Anesthesia Digest
- Vol. 33 (1) , 25-26
Impact of the HYPITAT Trial on Doctors’ Behaviour and Prevalence of Eclampsia in the Netherlands
(BJOG. 2011;118(13):1658-1660)
- Open Access
- 1 December 2012
- Published by Wolters Kluwer Health in Obstetrical & Gynecological Survey
- Vol. 67 (12) , 751-753
Should Cervical Favourability Play a Role in the Decision for Labour Induction in Gestational Hypertension or Mild Pre-eclampsia at Term? An Exploratory Analysis of the HYPITAT Trial
- 1 December 2012
- Published by Wolters Kluwer Health in Obstetrical & Gynecological Survey
- Vol. 67 (12) , 751-753
Open AccessShould Cervical Favourability Play a Role in the Decision for Labour Induction in Gestational Hypertension or Mild Pre-eclampsia at Term? An Exploratory Analysis of the HYPITAT Trial
- 10 October 2011
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 118 (13) , 1658-1660
Impact of the HYPITAT trial on doctors’ behaviour and prevalence of eclampsia in the Netherlands
Please cite this paper as: van der Tuuk K, Koopmans C, Groen H, Mol B, van Pampus M for the HYPITAT study group. Impact of the HYPITAT trial on doctors’ behaviour and prevalence of eclampsia in the Netherlands. BJOG 2011;118:1658–1660. We questioned if participation in the HYPITAT trial (induction of labour versus expectant monitoring in women with gestational hypertension or pre-eclampsia at term) impacted implementation of its results and subsequently maternal health. We identified women with hypertensive disease from the Perinatal Registry, and distinguished the period before, during and after the trial. We included 43 641 women. Induction of labour increased from 58.3 to 67.1% (P < 0.001) and prevalence of eclampsia decreased from 0.85 to 0.19% (P < 0.001) before and after the trial. Concurrently, participation in the HYPITAT trial among others had immediate consequences for obstetric management and maternal health.
- 10 October 2011
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 118 (13) , 1658-1660
Impact of the HYPITAT trial on doctors’ behaviour and prevalence of eclampsia in the Netherlands
Please cite this paper as: van der Tuuk K, Koopmans C, Groen H, Mol B, van Pampus M for the HYPITAT study group. Impact of the HYPITAT trial on doctors’ behaviour and prevalence of eclampsia in the Netherlands. BJOG 2011;118:1658–1660. We questioned if participation in the HYPITAT trial (induction of labour versus expectant monitoring in women with gestational hypertension or pre-eclampsia at term) impacted implementation of its results and subsequently maternal health. We identified women with hypertensive disease from the Perinatal Registry, and distinguished the period before, during and after the trial. We included 43 641 women. Induction of labour increased from 58.3 to 67.1% (P < 0.001) and prevalence of eclampsia decreased from 0.85 to 0.19% (P < 0.001) before and after the trial. Concurrently, participation in the HYPITAT trial among others had immediate consequences for obstetric management and maternal health.
- 18 April 2011
- Published by Wiley in Australian and New Zealand Journal of Obstetrics and Gynaecology
- Vol. 51 (4) , 339-346
Prediction of progression to a high risk situation in women with gestational hypertension or mild pre-eclampsia at term
To evaluate whether progression to a high-risk situation is predictable in women with gestational hypertension (GH) or mild pre-eclampsia (PE) at term. Women with a singleton pregnancy, a fetus in cephalic position, between 36 and 41 weeks of gestation, complicated by GH or mild PE that were managed expectantly, were selected from the HYPITAT trial. We evaluated the predictability of progression to a high-risk situation. Logistic regression was used to determine the predictive value of clinical characteristics or laboratory findings and to generate a prediction model for progression to a high-risk situation. The predictive value of this model was assessed with receiver-operating characteristic (ROC) analysis, calibration and internal validation. We included 703 women, of whom 244 (34.7%) had progression to a high-risk situation. After multivariable analysis, nulliparity (OR 1.87), maternal age (OR 1.05 per year), gestational age (OR 0.88 per week), previous abortion (OR 1.26), ethnicity (OR 2.05 for non-Caucasian ethnicity), diastolic (OR 1.04 per mmHg), systolic blood pressure (OR 1.02 per mmHg) and the laboratory parameters proteinuria, haemoglobin, platelets, uric acid and alanine aminotransferase were included in the final model. The area under the ROC curve of this model was 0.71 (95% CI, 0.67-0.74). Even though the goodness of fit was moderate (P=0.40), internal validation showed the model could hold in the overall population. In the prediction of progression to a high-risk situation, in women with GH or mild PE at term, a distinction can be made between women with a low risk and women with high risk.
- 18 April 2011
- Published by Wiley in Australian and New Zealand Journal of Obstetrics and Gynaecology
- Vol. 51 (4) , 339-346
Prediction of progression to a high risk situation in women with gestational hypertension or mild pre-eclampsia at term
To evaluate whether progression to a high-risk situation is predictable in women with gestational hypertension (GH) or mild pre-eclampsia (PE) at term. Women with a singleton pregnancy, a fetus in cephalic position, between 36 and 41 weeks of gestation, complicated by GH or mild PE that were managed expectantly, were selected from the HYPITAT trial. We evaluated the predictability of progression to a high-risk situation. Logistic regression was used to determine the predictive value of clinical characteristics or laboratory findings and to generate a prediction model for progression to a high-risk situation. The predictive value of this model was assessed with receiver-operating characteristic (ROC) analysis, calibration and internal validation. We included 703 women, of whom 244 (34.7%) had progression to a high-risk situation. After multivariable analysis, nulliparity (OR 1.87), maternal age (OR 1.05 per year), gestational age (OR 0.88 per week), previous abortion (OR 1.26), ethnicity (OR 2.05 for non-Caucasian ethnicity), diastolic (OR 1.04 per mmHg), systolic blood pressure (OR 1.02 per mmHg) and the laboratory parameters proteinuria, haemoglobin, platelets, uric acid and alanine aminotransferase were included in the final model. The area under the ROC curve of this model was 0.71 (95% CI, 0.67-0.74). Even though the goodness of fit was moderate (P=0.40), internal validation showed the model could hold in the overall population. In the prediction of progression to a high-risk situation, in women with GH or mild PE at term, a distinction can be made between women with a low risk and women with high risk.
- Open Access
- 3 November 2009
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 3 (1) , 103
Recurrent incarceration of the retroverted gravid uterus at term - two times transvaginal caesarean section: a case report
Persistent retroversion of a gravid uterus (incarceration) in the third trimester is an extremely rare diagnosis and is only scarcely been described. Its prevalence may lead to increased foetal mortality and maternal morbidity.
- 3 November 2009
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 3 (1) , 103
Open AccessRecurrent incarceration of the retroverted gravid uterus at term - two times transvaginal caesarean section: a case report
Persistent retroversion of a gravid uterus (incarceration) in the third trimester is an extremely rare diagnosis and is only scarcely been described. Its prevalence may lead to increased foetal mortality and maternal morbidity.